# OptimICE-pCR (NCT05812807)

> Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

No report yet. It can be ordered.

- Drugs tested: none (the trial tests a strategy, not a drug)
- Indication: early-stage triple-negative breast cancer with pathologic complete response

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05812807
- Phase: PHASE3
- Status: RECRUITING
- Sponsor: Alliance for Clinical Trials in Oncology
- Conditions: Anatomic Stage II Breast Cancer AJCC v8; Early Stage Triple-Negative Breast Carcinoma; Anatomic Stage IIIA Breast Cancer AJCC v8; Anatomic Stage IIIB Breast Cancer AJCC v8
- Interventions: Pembrolizumab; Patient Observation; Biopsy; Biospecimen Collection; Questionnaire Administration; Quality-of-Life Assessment
- Enrollment: 1295
- Primary outcome: Recurrence-free survival (RFS)

## Some of the questions raised in the 23 indexed sources

_Automated from all 23 indexed sources (Apr 2022 – Jul 2026). Each question is raised in at least two. Not an Erudio report: no source links. Not medical advice._

- Whether observation can replace adjuvant pembrolizumab after pCR to neoadjuvant chemotherapy plus pembrolizumab without losing benefit
- Whether omitting adjuvant pembrolizumab spares immune-related adverse events such as adrenal insufficiency and hypophysitis
- Which patients with pCR can safely omit adjuvant pembrolizumab, and whether MRD or ctDNA testing should guide it

## Indexed commentary on OptimICE-pCR so far

Podcasts, YouTube videos and posts on X and Bluesky we have indexed that name the trial. LinkedIn posts are read for reports and the Enterprise MCP, not yet for this index. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 17 posts on X
- 4 podcast episodes
- 2 YouTube videos

## Order

Deep, $1,950 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=optimice-pcr-nct05812807

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT05812807", "email": "<work email>"}; the inbox owner confirms by the emailed link.
